Literature DB >> 10333056

Variants in the sulphonylurea receptor gene: association of the exon 16-3t variant with Type II diabetes mellitus in Dutch Caucasians.

L M Hart1, P de Knijff, J M Dekker, R P Stolk, G Nijpels, F E van der Does, J B Ruige, D E Grobbee, R J Heine, J A Maassen.   

Abstract

AIMS/HYPOTHESIS: We have analysed to what extent two previously reported single nucleotide polymorphisms in the sulphonylurea receptor gene (SUR1) are associated with Type II (non-insulin-dependent) diabetes mellitus in The Netherlands. Furthermore, we estimated haplotype frequencies in control and diabetic populations, including data extracted from three other studies.
METHODS: Subjects with Type II diabetes (n = 388) and normoglycaemic subjects (n = 336) were randomly selected from two population-based studies, the Hoorn and Rotterdam studies. DNA was typed for variants in exon 16 (-3c-->t variant in the splice acceptor site) and exon 18 (Thr759Thr, ACC-->ACT).
RESULTS: The genotype frequencies in both populations were similar. We observed an association of the exon 16-3t variant with Type II diabetes (allele frequencies 0.41 % vs 0.48 % in NGT and Type II diabetes, respectively, p = 0.01). There was no association between Type II diabetes and the variant in exon 18 or the combination of both variants (p > 0.5). A strong linkage disequilibrium between the exon 16 and exon 18 variants was observed in the diabetic groups but not, or less pronounced, in the control groups from the different studies. Haplotype estimation shows that several different risk haplotypes exist in different Caucasian populations. CONCLUSION/
INTERPRETATION: The exon 16-3t allele of the SUR1 gene is associated with Type II diabetes in the Netherlands. Based on estimated haplotype frequencies in different Caucasian populations we conclude that multiple haplotypes on the SUR1 gene seem to confer a risk for developing Type II diabetes in Caucasians.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10333056     DOI: 10.1007/s001250051203

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  17 in total

Review 1.  The genetics of type 2 diabetes.

Authors:  M McCarthy; S Menzel
Journal:  Br J Clin Pharmacol       Date:  2001-03       Impact factor: 4.335

Review 2.  Candidate genes for type 2 diabetes.

Authors:  Hemang Parikh; Leif Groop
Journal:  Rev Endocr Metab Disord       Date:  2004-05       Impact factor: 6.514

Review 3.  KATP Channels in the Cardiovascular System.

Authors:  Monique N Foster; William A Coetzee
Journal:  Physiol Rev       Date:  2016-01       Impact factor: 37.312

Review 4.  Current status of the E23K Kir6.2 polymorphism: implications for type-2 diabetes.

Authors:  Michael J Riedel; Diana C Steckley; Peter E Light
Journal:  Hum Genet       Date:  2004-11-23       Impact factor: 4.132

5.  The Genetic Basis of Type 2 Diabetes.

Authors:  Swapan Kumar Das; Steven C Elbein
Journal:  Cellscience       Date:  2006-04-30

6.  Assignment of Functional Relevance to Genes at Type 2 Diabetes-Associated Loci Through Investigation of β-Cell Mass Deficits.

Authors:  Elizabeth A O'Hare; Laura M Yerges-Armstrong; James A Perry; Alan R Shuldiner; Norann A Zaghloul
Journal:  Mol Endocrinol       Date:  2016-03-10

Review 7.  Individualized therapy for type 2 diabetes: clinical implications of pharmacogenetic data.

Authors:  Gaia Chiara Mannino; Giorgio Sesti
Journal:  Mol Diagn Ther       Date:  2012-10       Impact factor: 4.074

Review 8.  Pharmacogenetic studies update in type 2 diabetes mellitus.

Authors:  Shalini Singh; Kauser Usman; Monisha Banerjee
Journal:  World J Diabetes       Date:  2016-08-10

Review 9.  Pharmacogenetics of glucose-lowering drug treatment: a systematic review.

Authors:  Ozlem Bozkurt; Anthonius de Boer; Diederick E Grobbee; Eibert R Heerdink; Huib Burger; Olaf H Klungel
Journal:  Mol Diagn Ther       Date:  2007       Impact factor: 4.074

10.  Disruption of ldlr causes increased LDL-c and vascular lipid accumulation in a zebrafish model of hypercholesterolemia.

Authors:  Elizabeth A O'Hare; Xiaochun Wang; May E Montasser; Yen-Pei C Chang; Braxton D Mitchell; Norann A Zaghloul
Journal:  J Lipid Res       Date:  2014-09-08       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.